proprietary Fenugreek extract from TSI Health Sciences, that’s standardized to provide 20% 4-hydroxyisoleucine.  TSI claims its in-house, pilot studies show Promilin can help reduce glucose concentrations in “healthy, non-diabetic individuals” without affecting insulin levels – but their data is not available on their web site; nor has it been published in any peer-reviewed journal.

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks